Barbara Hendrickson to Risk Assessment
This is a "connection" page, showing publications Barbara Hendrickson has written about Risk Assessment.
Connection Strength
0.074
-
Assessing adverse events in clinical trials during the era of the COVID-19 pandemic. J Biopharm Stat. 2023 07 04; 33(4):466-475.
Score: 0.028
-
Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions. Ther Innov Regul Sci. 2020 03; 54(2):447-461.
Score: 0.023
-
A Framework for Safety Evaluation Throughout the Product Development Life-Cycle. Ther Innov Regul Sci. 2020 07; 54(4):821-830.
Score: 0.023